Assessment of toxicity and biodistribution of recombinant AAV8 vector–mediated immunomodulatory gene therapy in mice with Pompe disease

A preclinical safety study was conducted to evaluate the short- and long-term toxicity of a recombinant adeno-associated virus serotype 8 (AAV2/8) vector that has been developed as an immune-modulatory adjunctive therapy to recombinant human acid α-glucosidase (rhGAA, Myozyme) enzyme replacement tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Gensheng, Young, Sarah P, Bali, Deeksha, Hutt, Julie, Li, Songtao, Benson, Janet, Koeberl, Dwight D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362383/
https://www.ncbi.nlm.nih.gov/pubmed/26015962
http://dx.doi.org/10.1038/mtm.2014.18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362383/
https://www.ncbi.nlm.nih.gov/pubmed/26015962
http://dx.doi.org/10.1038/mtm.2014.18

Ejemplares similares